Sectoral Asset Management’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Other funds holding AVBP
IAM
Sectoral Asset Management's AVBP Position: Q3 2026 in Review
Sectoral Asset Management increased its ArriVent BioPharma (AVBP) stake by 11% in Q3 2026, buying an estimated $254K and bringing the position to 87,343 shares worth $2.64M. The position accounts for 1.68% of the portfolio, ranked #18.
Sectoral Asset Management first reported a position in AVBP in Q1 2025 and has held it in 7 quarters since. The position peaked at $2.75M in Q2 2026. 151 funds tracked by Wall St. Rank hold AVBP as of Q3 2026.
- Sectoral Asset Management held 87,343 shares of ArriVent BioPharma worth $2.64M as of Q3 2026.
- Sectoral Asset Management bought 8,300 ArriVent BioPharma shares in Q3 2026, an estimated $254K.
- ArriVent BioPharma made up 1.68% of Sectoral Asset Management's portfolio in Q3 2026, its #18 holding.
- Sectoral Asset Management first reported a position in ArriVent BioPharma in Q1 2025 and has held it in 7 quarters since.
- Sectoral Asset Management's ArriVent BioPharma position peaked at $2.75M in Q2 2026.
- 151 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q3 2026.
Based on Sectoral Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.